MedPath
TGA Approval

ENZEEVU aflibercept 40 mg/mL solution for intravitreal injection vial with needle (445958)

445958

ENZEEVU aflibercept 40 mg/mL solution for intravitreal injection vial with needle

Sandoz Pty Ltd

May 27, 2025

Medicine

Medicine

Active

Registered

Active Ingredients

Aflibercept

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.